Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial

Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial

Bibliographic Details
Main Authors: David Macleod, Helen Anne Weiss, Matthew J Burton, Reena Yadav, Sandip Das Sanyam, Pankaj Chaudhary, Abhishek Roshan, Einoti Matayan
Format: Article
Language:English
Published: BMJ Publishing Group 2020-09-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/9/e038066.full
id doaj-7667b167dc774ab3b3442b02fe8f5087
record_format Article
spelling doaj-7667b167dc774ab3b3442b02fe8f50872021-07-21T16:12:51ZengBMJ Publishing GroupBMJ Open2044-60552020-09-0110910.1136/bmjopen-2020-038066Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trialDavid Macleod0Helen Anne Weiss1Matthew J Burton2Reena Yadav3Sandip Das Sanyam4Pankaj Chaudhary5Abhishek Roshan6Einoti Matayan7Tropical Epidemiology Group, Faculty of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UKEpidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UKInternational Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK20 Lady Hardinge Medical College, New Delhi, India Cornea Department, Sagarmatha Choudhary Eye Hospital, Lahan, NepalCornea Department, Sagarmatha Choudhary Eye Hospital, Lahan, NepalCornea Department, Sagarmatha Choudhary Eye Hospital, Lahan, NepalDepartment of Ophthalmology, Kilimanjaro Christian Medical Centre, Moshi, Tanzaniahttps://bmjopen.bmj.com/content/10/9/e038066.full
collection DOAJ
language English
format Article
sources DOAJ
author David Macleod
Helen Anne Weiss
Matthew J Burton
Reena Yadav
Sandip Das Sanyam
Pankaj Chaudhary
Abhishek Roshan
Einoti Matayan
spellingShingle David Macleod
Helen Anne Weiss
Matthew J Burton
Reena Yadav
Sandip Das Sanyam
Pankaj Chaudhary
Abhishek Roshan
Einoti Matayan
Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial
BMJ Open
author_facet David Macleod
Helen Anne Weiss
Matthew J Burton
Reena Yadav
Sandip Das Sanyam
Pankaj Chaudhary
Abhishek Roshan
Einoti Matayan
author_sort David Macleod
title Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial
title_short Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial
title_full Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial
title_fullStr Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial
title_full_unstemmed Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial
title_sort topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in nepal: rationale and design of a randomised controlled non-inferiority trial
publisher BMJ Publishing Group
series BMJ Open
issn 2044-6055
publishDate 2020-09-01
url https://bmjopen.bmj.com/content/10/9/e038066.full
work_keys_str_mv AT davidmacleod topicalchlorhexidine02versustopicalnatamycin5forfungalkeratitisinnepalrationaleanddesignofarandomisedcontrollednoninferioritytrial
AT helenanneweiss topicalchlorhexidine02versustopicalnatamycin5forfungalkeratitisinnepalrationaleanddesignofarandomisedcontrollednoninferioritytrial
AT matthewjburton topicalchlorhexidine02versustopicalnatamycin5forfungalkeratitisinnepalrationaleanddesignofarandomisedcontrollednoninferioritytrial
AT reenayadav topicalchlorhexidine02versustopicalnatamycin5forfungalkeratitisinnepalrationaleanddesignofarandomisedcontrollednoninferioritytrial
AT sandipdassanyam topicalchlorhexidine02versustopicalnatamycin5forfungalkeratitisinnepalrationaleanddesignofarandomisedcontrollednoninferioritytrial
AT pankajchaudhary topicalchlorhexidine02versustopicalnatamycin5forfungalkeratitisinnepalrationaleanddesignofarandomisedcontrollednoninferioritytrial
AT abhishekroshan topicalchlorhexidine02versustopicalnatamycin5forfungalkeratitisinnepalrationaleanddesignofarandomisedcontrollednoninferioritytrial
AT einotimatayan topicalchlorhexidine02versustopicalnatamycin5forfungalkeratitisinnepalrationaleanddesignofarandomisedcontrollednoninferioritytrial
_version_ 1721292409315262464

Similar Items